Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2023-08-23 00:00:00 ET · period of report 2023-08-23 · accession 0001062993-23-017040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-23 | 2023-08-23 | BIO | ERNST TIMOTHY S | EVP, GC, Sec | S - Sale | $384.69 | -300 | 2,416 | -11% | -$115.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2023-08-23 | S | D | 300 | $384.69 | 2,415.80 | D | — | — | (F1) Includes 19.319 and 25.114 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 3/31/2023 and 06/30/2023, respectively. |